| | | Single nucleotide variant (missense variant +1 more) | Lynch syndrome 5 +5 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant +1 more) | Familial cancer of breast +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +2 more) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant +2 more) | Familial cancer of breast +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Microcephaly +6 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Ataxia-telangiectasia syndrome +1 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (missense variant) | Breast and/or ovarian cancer +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Ataxia-telangiectasia syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant) | Ataxia-telangiectasia syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Ataxia-telangiectasia syndrome +6 more | GConflicting classifications of pathogenicity |
| | | Microsatellite (frameshift variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | ATM-related disorder +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Ataxia-telangiectasia syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +2 more) | Familial cancer of breast +4 more | |
| | | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +6 more | GConflicting classifications of pathogenicity |
| | | Copy number loss | Ataxia-telangiectasia syndrome +1 more | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Breast and/or ovarian cancer +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant) | Diffuse midline glioma, H3 K27-altered +3 more | GConflicting classifications of pathogenicity |
| | | Microsatellite (frameshift variant) | not provided +7 more | |
| | | Single nucleotide variant (missense variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Deletion (frameshift variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant) | Li-Fraumeni syndrome | |
| | RAD51D, RAD51L3-RFFL (S207L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | BRCA1, LOC126862571 (Q1064fs +20 more) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Microsatellite (frameshift variant +2 more) | BRCA1-related cancer predisposition | |
| | | Deletion (inframe_deletion) | Familial cancer of breast +5 more | |
| | | Deletion (nonsense) | Familial ovarian cancer +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (nonsense) | not provided +9 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | CHEK2-related cancer predisposition +9 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | CHEK2-related cancer predisposition +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +12 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | CHEK2-related cancer predisposition +9 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | NICE approved PARP inhibitor treatment +21 more | |
| | | Single nucleotide variant (missense variant +1 more) | Li-Fraumeni syndrome 2 +3 more | |
| | | Single nucleotide variant (missense variant) | Inherited breast cancer and ovarian cancer +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | not specified +14 more | GConflicting classifications of pathogenicity; risk factor |
| | | Single nucleotide variant (splice donor variant) | Inherited breast cancer and ovarian cancer +12 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | CHEK2-related cancer predisposition +14 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +8 more | |
| | | Single nucleotide variant (missense variant +1 more) | CHEK2-related cancer predisposition +9 more | GConflicting classifications of pathogenicity |